Gossamer Historical Financial Ratios
GOSS Stock | USD 0.77 0.05 6.10% |
Gossamer Bio is recently reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 2.33 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Gossamer Bio financial condition quickly.
Gossamer |
About Gossamer Financial Ratios Analysis
Gossamer BioFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Gossamer Bio investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Gossamer financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Gossamer Bio history.
Gossamer Bio Financial Ratios Chart
Add Fundamental
Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Most ratios from Gossamer Bio's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Gossamer Bio current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Gossamer Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.At this time, Gossamer Bio's Price Book Value Ratio is comparatively stable compared to the past year. Price Earnings To Growth Ratio is likely to gain to 0.01 in 2024, despite the fact that Free Cash Flow Yield is likely to grow to (1.09).
Gossamer Bio fundamentals Correlations
Click cells to compare fundamentals
Gossamer Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Gossamer Bio fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Ptb Ratio | (2.56) | (1.15) | (1.04) | (0.18) | 2.22 | 2.33 | |
Book Value Per Share | 6.44 | 4.68 | 1.62 | 0.14 | 0.41 | 0.39 | |
Free Cash Flow Yield | (0.18) | (0.3) | (0.23) | (1.02) | (1.14) | (1.09) | |
Operating Cash Flow Per Share | (2.65) | (2.57) | (2.52) | (2.21) | (1.04) | (1.09) | |
Pb Ratio | (2.56) | (1.15) | (1.04) | (0.18) | 2.22 | 2.33 | |
Free Cash Flow Per Share | (2.77) | (2.94) | (2.55) | (2.22) | (1.04) | (1.09) | |
Roic | 0.61 | 0.6 | 0.36 | 0.28 | (0.71) | (0.68) | |
Net Income Per Share | (3.3) | (3.67) | (3.33) | (2.84) | (1.18) | (1.24) | |
Payables Turnover | 3.23 | 0.57 | 1.59 | 3.04 | 0.79 | 1.25 | |
Cash Per Share | 7.34 | 7.48 | 4.35 | 3.02 | 1.94 | 2.79 | |
Pocfratio | (5.91) | (3.76) | (4.48) | (0.98) | (0.88) | (0.83) | |
Capex To Operating Cash Flow | (0.0453) | (0.14) | (0.008582) | (0.00254) | (0.002286) | (0.0024) | |
Pfcf Ratio | (5.65) | (3.29) | (4.44) | (0.98) | (0.88) | (0.83) | |
Days Payables Outstanding | 112.96 | 642.09 | 229.16 | 120.24 | 459.97 | 778.44 | |
Income Quality | 0.8 | 0.72 | 0.81 | 0.82 | 0.89 | 0.5 | |
Roe | 0.54 | 0.44 | 0.31 | 0.23 | (2.86) | (2.72) | |
Ev To Operating Cash Flow | (5.25) | (2.04) | (4.49) | (1.59) | (2.01) | (1.91) | |
Pe Ratio | (4.73) | (2.63) | (3.4) | (0.76) | (0.77) | (0.81) | |
Return On Tangible Assets | (0.61) | (0.42) | (0.47) | (0.72) | (0.88) | (0.58) | |
Ev To Free Cash Flow | (5.02) | (1.79) | (4.45) | (1.59) | (2.01) | (1.91) | |
Earnings Yield | (0.21) | (0.38) | (0.29) | (1.31) | (1.29) | (1.23) | |
Net Debt To E B I T D A | 0.51 | 1.29 | (0.008762) | (0.54) | (1.05) | (1.0) | |
Current Ratio | 11.09 | 13.51 | 8.32 | 5.32 | 5.94 | 5.63 | |
Tangible Book Value Per Share | 6.44 | 4.68 | 1.62 | 0.14 | 0.41 | 0.39 | |
Graham Number | 21.3 | 26.39 | 28.49 | 27.93 | 3.3 | 3.14 | |
Shareholders Equity Per Share | (6.1) | (8.43) | (10.84) | (12.2) | 0.41 | 0.43 | |
Capex Per Share | 0.12 | 0.36 | 0.0217 | 0.005616 | 0.006459 | 0.006136 | |
Graham Net Net | 5.97 | 4.29 | 1.38 | (0.0555) | 0.31 | 0.29 | |
Interest Debt Per Share | 0.52 | 2.7 | 2.65 | 2.76 | 1.46 | 1.03 | |
Enterprise Value Over E B I T D A | (4.08) | (1.54) | (4.05) | (1.41) | (1.86) | (1.95) | |
Price Earnings Ratio | (4.73) | (2.63) | (3.4) | (0.76) | (0.77) | (0.81) | |
Price Book Value Ratio | (2.56) | (1.15) | (1.04) | (0.18) | 2.22 | 2.33 | |
Price Earnings To Growth Ratio | (0.13) | (0.23) | 0.37 | 0.0519 | 0.0133 | 0.0139 | |
Days Of Payables Outstanding | 112.96 | 642.09 | 229.16 | 120.24 | 459.97 | 778.44 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.